Predict your next investment

ELECTRONICS | Chips & Semiconductors

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$10.43M

Valuation

$0000 

About Genia Technologies

Genia Technologies is a private company unifying Moore's Law with molecular diagnostics to make genetic information universally available. Genia's integrated circuits enable massively parallel, single-molecule DNA sequencing. Its versatile nanopore-based platform allows for single molecule, electrical real-time analysis without the need for complicated optics, labels, amplification, or fluidics. By developing a true integrated circuit on standard semiconductor process technology, Genia brings the benefits of genome sequencing out of the lab and into the everyday world.

Genia Technologies Headquarter Location

320 Logue Avenue

Mountain View, California, 94043,

United States

650-969-6565

Latest Genia Technologies News

In Brief This Week: University of California, William Blair, HTG Molecular Diagnostics, and More

Sep 28, 2018

NEW YORK (GenomeWeb) – It was announced this week that the lawsuit filed by the Regents of the University of California against Roger Chen and Genia Technologies was dismissed on July 18, following a settlement between the parties. The suit was originally filed in late 2016 and claimed that patents assigned to Genia resulted from work Chen performed while employed at the University of California, Santa Cruz. To read the full story....

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Genia Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Genia Technologies is included in 3 Expert Collections, including Genomics.

G

Genomics

823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data

N

Nanobiotechnology

707 items

These companies apply nanotechnology to clinical medicine. They research or develop highly specific, nanoscale interventions to aid in screening, diagnosis, and treatment of biological systems.

O

Omics

1,025 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Genia Technologies Patents

Genia Technologies has filed 107 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • DNA
  • Biotechnology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/27/2018

8/24/2021

Electrochemistry, Capacitors, Molecular biology, Nanotechnology, Sensors

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/27/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/24/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Electrochemistry, Capacitors, Molecular biology, Nanotechnology, Sensors

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.